Depression and Anxiety in Patients with Chronic Respiratory Diseases

205 Pages·2017·2.56 MB·English

by  Amir Sharafkhaneh

Depression and
Anxiety in Patients
with Chronic
Respiratory Diseases
Amir Sharafkhaneh
Abebaw Mengistu Yohannes
Nicola Alexander Hanania
Mark E. Kunik
Editors
123
Depression and Anxiety in Patients with Chronic
Respiratory Diseases
Amir Sharafkhaneh Abebaw Mengistu Yohannes
(cid:129)
Nicola Alexander Hanania Mark E. Kunik
(cid:129)
Editors
Depression and Anxiety
in Patients with Chronic
Respiratory Diseases
123
Editors
Amir Sharafkhaneh, MD, PhD
Professorof Medicine
Department ofMedicine
BaylorCollege ofMedicine
Staff Physician
Michael E. DeBakeyVAMedical Center
Houston, TX,USA
Abebaw MengistuYohannes, PhD,MSc
Department ofHealth Professions
ManchesterMetropolitan University
Manchester, UK
NicolaAlexander Hanania, MD, MS,FCCP
BaylorCollege ofMedicine
Houston, TX,USA
Mark E. Kunik, MD, MPH
BaylorCollege ofMedicine
Houston, TX,USA
ISBN978-1-4939-7007-0 ISBN978-1-4939-7009-4 (eBook)
DOI 10.1007/978-1-4939-7009-4
LibraryofCongressControlNumber:2017933272
©SpringerScience+BusinessMediaLLC2017
Thisworkissubjecttocopyright.AllrightsarereservedbythePublisher,whetherthewholeorpart
of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations,
recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission
orinformationstorageandretrieval,electronicadaptation,computersoftware,orbysimilarordissimilar
methodologynowknownorhereafterdeveloped.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this
publicationdoesnotimply,evenintheabsenceofaspecificstatement,thatsuchnamesareexemptfrom
therelevantprotectivelawsandregulationsandthereforefreeforgeneraluse.
The publisher, the authors and the editors are safe to assume that the advice and information in this
book are believed to be true and accurate at the date of publication. Neither the publisher nor the
authorsortheeditorsgiveawarranty,expressorimplied,withrespecttothematerialcontainedhereinor
for any errors or omissions that may have been made. The publisher remains neutral with regard to
jurisdictionalclaimsinpublishedmapsandinstitutionalaffiliations.
Printedonacid-freepaper
ThisSpringerimprintispublishedbySpringerNature
TheregisteredcompanyisSpringerScience+BusinessMediaLLC
Theregisteredcompanyaddressis:233SpringStreet,NewYork,NY10013,U.S.A.
Preface
As populations age, the prevalence of chronic respiratory conditions increases
steadily. Further, recent advances in various health-related fields have been
extending human longevity. Undoubtedly, chronic medical conditions, with no
exception for chronic respiratory conditions, affect quality of life negatively and
result in various psychiatric conditions including depression and anxiety. Thus, as
theprevalenceofchronicmedicalconditionsincreases,theprevalenceofassociated
psychiatric conditions increases too. In this book, we aim at evaluating various
chronic respiratory conditions associated with psychiatric comorbidities and
explore the management options available. Chapters 1–8 are dedicated to psychi-
atric conditions in various respiratory problems. In Chap. 1, Drs. Rose and
Sharafkhaneh provide a general overview of respiratory conditions and how they
promote depression and other psychiatric comorbidities. In Chap. 2, Drs. Dooley
and Kunik review depression and anxiety across various age groups. In Chap. 3,
Drs. Yohannes and Willgross discuss various tools that are used to assess
depression and anxiety. Drs. Majid and Nadim, in Chap. 4, focus on chronic
obstructive pulmonary disease (COPD) and depression. In Chap. 6, Drs. Malatack
and Barto explore depression and anxiety in patients with cystic fibrosis. Dr. Sista
and colleagues, in Chap. 7, focus on psychiatric conditions in end-stage lung dis-
easeandlungtransplantation.Finally,Drs.HasmiandKhawajaexplorepsychiatric
conditionsinsleepdisorders.Thesecondpartofthisbookfocusesonmanagement
strategiesincludingpharmacologicalandnon-pharmacologicalinterventionstotreat
depression and anxiety in patients with chronic respiratory conditions. Chapter 10,
by Drs. Hynninen and Nordus, brings our attention to non-pharmacological inter-
vention while Chap. 11, by Drs. Yohannes and Leroi, focuses on medication for
depression and anxiety. At last, Drs. Ponti and Braun explore end-of-life issues in
patients with advanced respiratory conditions. We hope that this collection of
chaptersfrompractitionersandresearcherswithdifferentmedicalbackgroundscan
v
vi Preface
provide a solid basis for clinicians who take care of patients with chronic and
advanced lung diseases. We would like to thank the staff at Springer for their
tremendous help to make this project successful.
Houston, TX, USA Amir Sharafkhaneh, MD, PhD
Contents
1 Overview of Psychological Considerations in the Management
of Patients with Chronic Respiratory Conditions .. .... ..... .... 1
Mary Rose and Amir Sharafkhaneh
2 Depression and Anxiety Across the Age Spectrum. .... ..... .... 11
Erin Dooley and Mark E. Kunik
3 Diagnostic Tools for Anxiety and Depression . .... .... ..... .... 33
Abebaw Mengistu Yohannes and Thomas George Willgoss
4 Anxiety and Depression in COPD Patients ... .... .... ..... .... 57
Hashir Majid and Tania Nadeem
5 Depression and Anxiety in Adult Patients with Asthma. ..... .... 73
Abebaw Mengistu Yohannes and Nicola Alexander Hanania
6 Depression and Anxiety in the Cystic Fibrosis Population.... .... 85
James Joseph Malatack and Tara Lynn Barto
7 End-Stage Lung Disease and Lung Transplantation.... ..... .... 97
Kapil Rangavajhala, Kathryn Blanchard
and Ramachandra R. Sista
8 Sleep-Disordered Breathing and Mental Illness ... .... ..... .... 109
Ali Madeeh Hashmi and Imran Shuja Khawaja
9 The Impact of Comorbidities in Patients with Chronic
Respiratory Diseases.... ..... .... .... .... .... .... ..... .... 129
Abebaw Mengistu Yohannes
10 Non-pharmacological Interventions to Manage Depression
and Anxiety Associated with Chronic Respiratory Diseases:
Cognitive Behavioral Therapy and Others ... .... .... ..... .... 149
Minna J. Hynninen and Inger Hilde Nordhus
vii
viii Contents
11 Pharmacological Therapy and Anxiolytics in Patients with
Respiratory Diseases.... ..... .... .... .... .... .... ..... .... 167
Abebaw Mengistu Yohannes and Iracema Leroi
12 Palliative and End-of-Life Issues in Patients with Advanced
Respiratory Diseases.... ..... .... .... .... .... .... ..... .... 183
Glencora Sharfman and Ursula K. Braun
Index .... .... .... .... .... ..... .... .... .... .... .... ..... .... 195
Contributors
TaraLynnBarto,MD DivisionofPulmonary,CriticalCareandSleepMedicine,
Baylor College of Medicine, Houston, TX, USA
Kathryn Blanchard, LCSW Division of Pulmonary Medicine, Phoenix, AZ,
USA
Ursula K. Braun, MD, MPH Michael E. DeBakey VA Medical Center and
CenterforInnovationsinQuality,EffectivenessandSafety(IQuESt),Houston,TX,
USA; Baylor College of Medicine, Houston, TX, USA
Erin Dooley, MD Department of Psychiatry, University of Virginia,
Charlottesville, VA, USA
Nicola Alexander Hanania, MD, MS, FCCP Department of Pulmonary and
Critical Care, Baylor College of Medicine, Houston, TX, USA
Ali Madeeh Hashmi, MBBS, MD King Edward Medical University/Mayo
Hospital, Lahore, Pakistan
MinnaJ.Hynninen,PhD NKSOlaviken,HospitalforOldAgePsychiatry,Erdal,
Norway; Department of Clinical Psychology, University of Bergen, Bergen,
Norway
Imran ShujaKhawaja, MD Center forSleep Medicine, VANorthTexasHealth
Care System, Dallas, TX, USA; Psychiatry and Neurology, UT Southwestern
Medical Center, Dallas, TX, USA
Mark E. Kunik, MD, MPH Baylor College of Medicine, Houston, TX, USA
Iracema Leroi, MD The University of Manchester, Manchester, UK
Hashir Majid, MBBS, FCCP Section of Pulmonary and Critical Care Medicine,
Department of Medicine, Aga Khan University, Karachi, Pakistan
James Joseph Malatack, MD Division of Hospital Medicine, Medstar
Georgetown University Hospital, Washington, DC, USA
ix
x Contributors
Tania Nadeem, MBBS, MD Department of Psychiatry, Aga Khan University,
Karachi, Pakistan
Inger Hilde Nordhus, PhD Faculty of Psychology, Department of Clinical
Psychology, University of Bergen, Bergen, Norway; Faculty of Medicine,
Department of Behavioural Sciences in Medicine, University of Oslo, Oslo,
Norway
Kapil Rangavajhala, MD Division of Pulmonary Medicine, Phoenix, AZ, USA
Mary Rose, PsyD TIRR Memorial Hermann, Houston, TX, USA
Amir Sharafkhaneh, MD, PhD Department of Medicine, Baylor College of
Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, USA
Glencora Sharfman, MD Baylor College of Medicine, Houston, TX, USA
Ramachandra R. Sista, MD Division of Pulmonary Medicine, Phoenix, AZ,
USA
Thomas George Willgoss, PhD, MSc Department of Health Professions,
Manchester Metropolitan University, Manchester, UK
Abebaw Mengistu Yohannes, PhD, MSc Department of Health Professions,
Manchester Metropolitan University, Manchester, UK